Literature DB >> 12384394

parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

Rodrigo Alonso, Marc Galimand, Patrice Courvalin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12384394      PMCID： PMC128750          DOI： 10.1128/AAC.46.11.3686-3687.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.

Authors:  Xinying Li; Xilin Zhao; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.

Authors:  R Muñoz; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

3.  Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

Authors:  X S Pan; J Ambler; S Mehtar; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 4.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

5.  In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones.

Authors:  Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Karl Köhrer; Sibylle Scheuring; Ad C Fluit
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 6.  Group A streptococci in the 1990s.

Authors:  A Efstratiou
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

7.  Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.

Authors:  L M Weigel; G J Anderson; R R Facklam; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.

Authors:  D J Bast; D E Low; C L Duncan; L Kilburn; L A Mandell; R J Davidson; J C de Azavedo
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

9.  Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance.

Authors:  S S Yan; M L Fox; S M Holland; F Stock; V J Gill; D P Fedorko
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

10.  Isolation of transformation-deficient Streptococcus pneumoniae mutants defective in control of competence, using insertion-duplication mutagenesis with the erythromycin resistance determinant of pAM beta 1.

Authors:  D A Morrison; M C Trombe; M K Hayden; G A Waszak; J D Chen
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490
View more
  5 in total

1.  Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes.

Authors:  Rodrigo Alonso; Estibaliz Mateo; Marc Galimand; Javier Garaizar; P Courvalin; Ramón Cisterna
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

2.  First characterization of fluoroquinolone resistance in Streptococcus suis.

Authors:  Jose Antonio Escudero; Alvaro San Millan; Ana Catalan; Adela G de la Campa; Estefania Rivero; Gema Lopez; Lucas Dominguez; Miguel Angel Moreno; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.

Authors:  Jeff Powis; Allison McGeer; Carla Duncan; Ryan Goren; Joyce C S de Azavedo; Darrin J Bast; Sylvia Pong-Porter; Tony Mazzulli; Karen Green; Barbara Willey; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  CovRS-Regulated Transcriptome Analysis of a Hypervirulent M23 Strain of Group A Streptococcus pyogenes Provides New Insights into Virulence Determinants.

Authors:  Yun-Juan Bao; Zhong Liang; Jeffrey A Mayfield; Shaun W Lee; Victoria A Ploplis; Francis J Castellino
Journal:  J Bacteriol       Date:  2015-07-27       Impact factor: 3.490

5.  An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.

Authors:  S Steve Yan; Paul C Schreckenberger; Xiaotian Zheng; Nancy A Nelson; Susan M Harrington; Joyce Tjhio; Daniel P Fedorko
Journal:  Diagn Microbiol Infect Dis       Date:  2008-06-12       Impact factor: 2.803
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.